Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for NOAC-associated intracerebral hemorrhage
NCT02866838Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Dec 2016
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in intracerebral hemorrhage (ICH), sponsored by University Hospital Basel. Primary endpoint: Hematoma expansion at 27 hours. Started Dec 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT02866838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866838.